Umifenovir

Referência M38807-50mg

Tamanho : 50mg

Marca : AbMole Bioscience

Contactar o distribuidor local :


Telefone : +1 850 650 7790

Umifenovir Structure

Quality Control & Documentation
Biological Activity

Umifenovir is a potent, orally active broad-spectrum antiviral agent with activity against a number of enveloped and non-enveloped viruses. Umifenovir is an efficient inhibitor of SARS-CoV-2 in vitro.

Chemical Information
Molecular Weight 477.41
Formula C22H25BrN2O3S
CAS Number 131707-25-0
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Serap Şimşek-Yavuz et al. Turk J Med Sci. An update of anti-viral treatment of COVID-19

[2] Behnam Amani et al. Immun Inflamm Dis. Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis

[3] Ilad Alavi Darazam et al. Int Immunopharmacol. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial

[4] I A Leneva et al. Ter Arkh. [Umifenovir and coronavirus infections: a review of research results and clinical practice]

[5] Marzieh Nojomi et al. BMC Infect Dis. Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial